Covariates KAINATE and TARIQUIDAR were set to 1 for treated animals and to 0 for nontreated animals. All θ and η were estimated in optimization of model. Interanimal variability, described by exponential variance model—that is, exp(η)—was investigated for all structural model parameters but kept in model only if model was significantly improved by inclusion.